<p>Profound Medical Corp. (TSE:PRN - 获取免费报告) 的股价在周二的午盘交易中达到了新的 52 周高点。该股最高交易价为 C$12.40，最后交易价为 C$11.85，成交量为 11025 股。该股此前收盘价为 C$12.11。</p>
<p>获取 <strong>Profound Medical</strong> 的提醒：</p>
<h2>Profound Medical 股票表现</h2>
<p>该公司的债务与股本比率为 20.05，速动比率为 14.98，流动比率为 6.12。公司的市值为 4.21 亿加元，市盈率为-8.79，贝塔值为 1.19。该业务的 50 日移动平均线为 C$9.67，200 日移动平均线为 C$8.15。</p>
<p>Profound Medical (TSE:PRN - 获取免费报告) 最近在 11 月 13 日（星期四）发布了其财报。该公司报告本季度每股收益为 C$0.26。Profound Medical 的股本回报率为-85.22%，净利润率为-349.41%。该业务在本季度的收入为 736 万加元。卖方分析师平均预测 Profound Medical Corp. 在当前财政年度将发布-1.9000001 的每股收益。</p>
<h2>Profound Medical 公司简介</h2>
<p>(获取免费报告)</p>
<p>Profound Medical Corp. 及其子公司作为一家商业阶段的医疗设备公司，开发和销售无切口的治疗系统，用于在加拿大、德国、美国和芬兰进行影像引导的病变组织消融。其主打产品 TULSA-PRO 系统结合了磁共振成像（MRI）、机器人驱动的经尿道清扫动作/热超声和闭环温度反馈控制，以提供外科医生定义区域的精确、灵活和持久的消融，并保护尿道和直肠。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票比 Profound Medical 更好</li>
<li>Elon 将 SpaceX 上市！$100 的首次公开募股机会！</li>
<li>家族信托如何帮助保护您的财富</li>
<li>一项价值数万亿的美国 “出生权” 索赔 - 静悄悄地激活</li>
<li>这只股票获得 94 分（满分 100 分）</li>
<li>自 2007 年以来首次：所有警告均已激活</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>您现在应该投资$1,000 在 Profound Medical 吗？</h2>
<p>在您考虑 Profound Medical 之前，您需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Profound Medical 并不在名单上。</p>
<p>虽然 Profound Medical 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

PROF

<p>Profound Medical（多伦多证券交易所代码：PRN）在交易中达到了新的 52 周高点 C$12.40，收盘价为 C$11.85。该公司的市值为 C$4.21 亿，市盈率为-8.79，报告的收入为 C$736 万，预计本财年的每股收益为-1.90。分析师目前对该股票的评级为持有，建议可能有更好的投资选择</p>

<p>Profound Medical Corp. (TSE:PRN - Get Free Report)'s stock price reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as C$12.40 and last traded at C$11.85, with a volume of 11025 shares traded. The stock had previously closed at C$12.11.</p>
<div class="lb-trans"><p>Profound Medical Corp. (TSE:PRN - 获取免费报告) 的股价在周二的午盘交易中达到了新的 52 周高点。该股最高交易价为 C$12.40，最后交易价为 C$11.85，成交量为 11025 股。该股此前收盘价为 C$12.11。</p>
</div><p>Get <strong>Profound Medical</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Profound Medical</strong> 的提醒：</p>
</div><h2>Profound Medical Stock Performance</h2>
<div class="lb-trans"><h2>Profound Medical 股票表现</h2>
</div><p>The company has a debt-to-equity ratio of 20.05, a quick ratio of 14.98 and a current ratio of 6.12. The company has a market capitalization of C$421.00 million, a P/E ratio of -8.79 and a beta of 1.19. The business has a 50 day moving average of C$9.67 and a 200-day moving average of C$8.15.</p>
<div class="lb-trans"><p>该公司的债务与股本比率为 20.05，速动比率为 14.98，流动比率为 6.12。公司的市值为 4.21 亿加元，市盈率为-8.79，贝塔值为 1.19。该业务的 50 日移动平均线为 C$9.67，200 日移动平均线为 C$8.15。</p>
</div><p>Profound Medical (TSE:PRN - Get Free Report) last issued its earnings results on Thursday, November 13th. The company reported C$0.26 EPS for the quarter. Profound Medical had a negative return on equity of 85.22% and a negative net margin of 349.41%.The business had revenue of C$7.36 million during the quarter. On average, sell-side analysts predict that Profound Medical Corp. will post -1.9000001 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Profound Medical (TSE:PRN - 获取免费报告) 最近在 11 月 13 日（星期四）发布了其财报。该公司报告本季度每股收益为 C$0.26。Profound Medical 的股本回报率为-85.22%，净利润率为-349.41%。该业务在本季度的收入为 736 万加元。卖方分析师平均预测 Profound Medical Corp. 在当前财政年度将发布-1.9000001 的每股收益。</p>
</div><h2>Profound Medical Company Profile</h2>
<div class="lb-trans"><h2>Profound Medical 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.</p>
<div class="lb-trans"><p>Profound Medical Corp. 及其子公司作为一家商业阶段的医疗设备公司，开发和销售无切口的治疗系统，用于在加拿大、德国、美国和芬兰进行影像引导的病变组织消融。其主打产品 TULSA-PRO 系统结合了磁共振成像（MRI）、机器人驱动的经尿道清扫动作/热超声和闭环温度反馈控制，以提供外科医生定义区域的精确、灵活和持久的消融，并保护尿道和直肠。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Profound Medical</li>
<li>Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!</li>
<li>How a Family Trust May Be Able To Help Preserve Your Wealth</li>
<li>A U.S. “birthright” claim worth trillions - activated quietly</li>
<li>This stock gets a 94 out of 100</li>
<li>First Time Since 2007: All Warnings Active</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Profound Medical 更好</li>
<li>Elon 将 SpaceX 上市！$100 的首次公开募股机会！</li>
<li>家族信托如何帮助保护您的财富</li>
<li>一项价值数万亿的美国 “出生权” 索赔 - 静悄悄地激活</li>
<li>这只股票获得 94 分（满分 100 分）</li>
<li>自 2007 年以来首次：所有警告均已激活</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Profound Medical Right Now?</h2>
<div class="lb-trans"><h2>您现在应该投资$1,000 在 Profound Medical 吗？</h2>
</div><p>Before you consider Profound Medical, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考虑 Profound Medical 之前，您需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Profound Medical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Profound Medical 并不在名单上。</p>
</div><p>While Profound Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Profound Medical 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Profound Medical（TSE:PRN）创下 1 年新高 - 现在是买入的好时机吗？